NCT05531448

Brief Summary

Investigators aim to demonstrate that interactive, two-way texting (2WT) to remind patients about their clinic visits and engage patients in their health can increase antiretroviral therapy (ART) retention in a routine setting in Lilongwe Malawi.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
467

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 8, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

December 16, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

September 3, 2022

Last Update Submit

May 12, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Retention

    ART retention at 6 months post initiation (e.g., alive on ART, transferred out, dead, ART disruption)

    6 months

  • Referrals to tracing

    Cumulative B2C referrals at 6 months as a measure of patients referred to tracing after missing scheduled ART drug dispensing visits.

    6 months

Study Arms (2)

2wT (2-way texting)

EXPERIMENTAL

2wT participants will receive weekly motivational messages without any HIV-related information. They will receive visit reminders with an option to respond they will attend, they transfered, or they need scheduling help. If they do not attend their visit, they will be traced at 14 days.

Other: two way texting

Routine retention

NO INTERVENTION

Control participants will have routine Back to Care retention support services and tracing at 14 days after a visit it missed.

Interventions

Automated 2WT-based adherence support messages combined with scheduled visit reminders focus on preventing visit default will be implemented. One-way "blast" motivational support messages will be sent to all new ART patients who opt-into 2WT. ART visit reminders 3- and 1- day before visits will ask clients to respond with 1=attend and 0=no, triggering 2wT responses to clients to reschedule visits, record transfers, etc. 2WT clerks proactively communicate with clients before a visit to prevent default or ascertain true outcomes for those who don't return. Those who miss visits receive additional 2wT reminders. On day 14 post visit, 2wT patients who missed visits, did not respond to text or did not have outcomes updated (transfer, stop, etc.), are identified by the 2WT system and referred to B2C for tracing, days or months earlier than routine B2C. The 2wT-generated tracing list is more timely and accurate, reducing workload and increasing B2C effectiveness

2wT (2-way texting)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- new ART initiates (0-6 months on ART) at LH (including transfer in) aged 18 years and above has mobile phone at enrollment written consent confirmed SMS enrollment receipt willing to receive/send SMS

You may not qualify if:

  • \- No cell phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Lighthouse Trust

Lilongwe, Malawi

Location

Martin Preuss Centre

Lilongwe, Malawi

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: patients eligible for 2wT who consent will be randomized 1:1 into routine retention care an 2wT-based retention care. At 6 months, control arm participants will receive also receive 2wT and continue in 2wT as part of routine Lighthouse retention activities under the umbrella R33 NIH-funded quasi-experimental study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 3, 2022

First Posted

September 8, 2022

Study Start

December 16, 2022

Primary Completion

December 28, 2023

Study Completion

August 1, 2024

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

All collected de-identified data will be shared between researchers and via datasets attached to publications.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After results are finalized and will be published in an open access journal.
Access Criteria
de-identified data will be available in Dryad

Locations